Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride + Alpha Blocker for Refractory Urinary Retention in BPH
NCT00680680Phase 4Completed
- Sponsor
- Franklin D. Gaylis, MD
- Start
- May 2004
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by Franklin D. Gaylis, MD. Started May 2004; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00680680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680680.